Increasing multimonth dispensing of antiretrovirals and assessing the effect on viral load suppression among children and adolescents receiving HIV services in Nigeria
Fig 5
Proportion of CALHIV ages 2–18 years currently on ART, on optimized pediatric regimens, on MMD, and virally suppressed at 36 SIDHAS-supported sites, by quarter (October 2019–March 2021).